Skip to main content
The Journal

In A Landmark Trial, Zuckerberg Takes the Stand

21 min episode · 2 min read

Episode

21 min

Read time

2 min

Topics

Health & Wellness, Leadership, Design & UX

AI-Generated Summary

Key Takeaways

  • Legal strategy shift: Previous lawsuits against Meta failed because Section 230 of the 1996 Communications Decency Act shields platforms from liability over third-party content. Plaintiffs now bypass this by targeting app design itself — infinite scroll, autoplay, push notifications, personalized algorithms — framing these as product liability issues Meta is directly responsible for creating and deploying.
  • Internal beauty filter research: In 2019, Meta commissioned 18 independent experts to evaluate whether Instagram beauty filters caused harm to users. All 18 concluded the filters were harmful to teenage girls. Despite this unanimous finding, Zuckerberg approved their return, citing insufficient "evidenced harm" — a decision now central to the plaintiff's case against the company.
  • Under-13 user scale: A 2015 internal Meta email, submitted as trial evidence, estimated approximately 4 million children under 13 were actively using Instagram — representing roughly 30% of all US children aged 10 to 12. Meta's minimum age is 13, but the company acknowledged it lacks reliable tools to identify and remove underage users.
  • Engagement goals as evidence: A 2015 internal Zuckerberg email explicitly set a goal to increase user time-on-platform by 12% the following year. Plaintiff attorneys use this document to argue Meta deliberately engineered addictiveness for ad revenue growth. Zuckerberg acknowledged the email but testified the company no longer sets explicit time-spent targets.
  • Bellwether trial implications: This LA case seeks only monetary damages for one plaintiff, but its outcome functions as a bellwether for thousands of pending cases nationwide. A plaintiff victory would not eliminate Section 230 protections but would establish a viable legal route holding platforms accountable specifically for design decisions, creating precedent across the entire social media industry.

What It Covers

Meta CEO Mark Zuckerberg testifies in a Los Angeles jury trial — the first of thousands of product liability cases — where plaintiff KGM, now 20, claims Instagram and Facebook caused mental health harm beginning at age 10, potentially reshaping how social media platforms are designed and regulated across the US.

Key Questions Answered

  • Legal strategy shift: Previous lawsuits against Meta failed because Section 230 of the 1996 Communications Decency Act shields platforms from liability over third-party content. Plaintiffs now bypass this by targeting app design itself — infinite scroll, autoplay, push notifications, personalized algorithms — framing these as product liability issues Meta is directly responsible for creating and deploying.
  • Internal beauty filter research: In 2019, Meta commissioned 18 independent experts to evaluate whether Instagram beauty filters caused harm to users. All 18 concluded the filters were harmful to teenage girls. Despite this unanimous finding, Zuckerberg approved their return, citing insufficient "evidenced harm" — a decision now central to the plaintiff's case against the company.
  • Under-13 user scale: A 2015 internal Meta email, submitted as trial evidence, estimated approximately 4 million children under 13 were actively using Instagram — representing roughly 30% of all US children aged 10 to 12. Meta's minimum age is 13, but the company acknowledged it lacks reliable tools to identify and remove underage users.
  • Engagement goals as evidence: A 2015 internal Zuckerberg email explicitly set a goal to increase user time-on-platform by 12% the following year. Plaintiff attorneys use this document to argue Meta deliberately engineered addictiveness for ad revenue growth. Zuckerberg acknowledged the email but testified the company no longer sets explicit time-spent targets.
  • Bellwether trial implications: This LA case seeks only monetary damages for one plaintiff, but its outcome functions as a bellwether for thousands of pending cases nationwide. A plaintiff victory would not eliminate Section 230 protections but would establish a viable legal route holding platforms accountable specifically for design decisions, creating precedent across the entire social media industry.

Notable Moment

Plaintiff attorneys unrolled a 35-foot banner requiring seven people to hold it upright, displaying every Instagram post KGM made from age 10 onward. Shown directly to Zuckerberg and the jury, the visual demonstrated the platform's decade-long presence in one teenager's life.

Know someone who'd find this useful?

Episode Transcript

So it is 06:30AM, and it has just stopped raining. I am waiting outside a courthouse trying to get into this trial that is happening today. Yesterday morning, our colleague Megan Bobrowski was in Los Angeles. She was there for a landmark trial and to watch testimony from a very high profile witness. Meta CEO Mark Zuckerberg is supposed to testify, and Mark Zuckerberg is going to be defending himself and the actions of his company today in court. The key questions hanging over Zuckerberg's testimony, is social media designed to be addictive? And is it harmful to teenagers? Last week, the plaintiff's attorney, Mark Lanier, spoke about the case on Fox Business. Well, we slapped a subpoena on Mark Zuckerberg on purpose because we've got documents with his name that he authored, that we believe show he put profits over the safety of children. Lanier represents a 20 year old woman who claims that she was harmed by social media use as a child. And and we're gonna put him on the stand and I'm gonna grill him on him. Meta, which is the parent company of Facebook and Instagram, said in a statement prior to the trial's start that the plaintiff's lawyers will quote, try to paint an intentionally misleading picture of Meta with cherry picked quotes and snippets of conversations taken out of context. This trial, which is being heard by a jury, is the first of its kind and the first of thousands of similar cases that are expected to go to court in the coming years. Here's Megan again. These cases are focused on how Meta designed its apps and whether Meta designed its apps to be addictive to people. That is a new argument that we're seeing. So the outcome could fundamentally change how the company operates. This could be a very big reckoning moment for big tech, and, social media might not ever look the same after this is said and done. Welcome to The Journal, our show about money, business, and power. I'm Ryan Knudson. It's Thursday, February 19. Coming up on the show, social media on trial. For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremfya offers self injection or intravenous infusion from the start. Tremfia is administered as injections under the skin or infusions through a vein every four weeks, followed by injections under the skin every four or eight weeks. If your doctor decides that you can self inject Tremfia, proper training is required. Tremfya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and adults with moderately to severely active ulcerative colitis. Serious allergic reactions and increased risk of infections and liver problems may occur. Before treatment, your doctor should check you for infections and tuberculosis. Tell your doctor if you have an infection, flu like symptoms, or if you need a vaccine. Explore what's possible. Ask your doctor about Tremfya today. Call +1 805267736 to learn more, …

Get the full transcript (3,132 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all The Journal transcripts →

You just read a 3-minute summary of a 18-minute episode.

Get The Journal summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from The Journal

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best News Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into The Journal.

Every Monday, we deliver AI summaries of the latest episodes from The Journal and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime